WSR 16-15-087
(Washington Apple Health)
[Filed July 20, 2016, 9:23 a.m.]
Subject of Possible Rule Making: WAC 182-530-1050 Definitions, 182-530-3100 How the medicaid agency determines when a drug requires authorization, 182-530-4100 Washington preferred drug list (PDL), 182-530-4125 Generics first for a client's first course of treatment, 182-530-4150 Therapeutic interchange program (TIP), and other rules as appropriate.
Statutes Authorizing the Agency to Adopt Rules on this Subject: RCW 41.05.021, 41.05.160.
Reasons Why Rules on this Subject may be Needed and What They Might Accomplish: The agency is amending these rules to increase the number of drug classes eligible for supplemental rebates. Housekeeping updates will also be made as a result of these changes. During the course of this review, the agency may identify additional changes that are required in order to improve clarity or update policy.
Process for Developing New Rule: The agency welcomes the public to take part in developing this rule. If interested, contact the person identified below to receive an early rule draft to review. After the early review, the agency will send a notice of proposed rule making (CR-102) to everyone receiving this notice and anyone who requests a copy.
Interested parties can participate in the decision to adopt the new rule and formulation of the proposed rule before publication by contacting Katie Pounds, P.O. Box 42716, Olympia, WA 98504-2716, fax (360) 586-9727, TTY 1-800-848-5429, e-mail
July 20, 2016
Wendy Barcus
Rules Coordinator